Paul Sunzenauer
Junior Investment Manager (Life Sciences) @ OCCIDENT
Munich, Germany
Paul Sunzenauer is a pre-seed investor at OCCIDENT in Munich focused on Life Science and Biotechnology. Paul Sunzenauer
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Paul Sunzenauer invests in
Stages Paul Sunzenauer invests in
Countries Paul Sunzenauer invests in
Investment Focus
Industry
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Immitra Bio
|
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful biomedical technologies: hematopoietic stem cells (HSCs) and CRISPR-Cas9 gene editing. Our novel technique allows for precise and long-lasting gene alterations within blood stem cells, resulting in transformational treatments for uncommondiseases with significant unmet medical needs. | $2.8M / Pre-Seed / Jul 21, 2026 |
Co-Investors
another.vc
1 deal together
BackBone Ventures
1 deal together
ETH Zurich Foundation
1 deal together
FONGIT
1 deal together
Kickfund
1 deal together
Venture Kick
1 deal together
About OCCIDENT
Occident is an international, privately held investment company based in Zug and Munich. Our goal is to manage our own wealth in a sustainable, meaningful manner seeking to make a positive contribution to society through our investments. Venture Capital is the focus of our investment activities. We see ourselves as a long-term oriented enabler forinnovative start-ups and visionary founders. As a complementary team of experts, we are fascinated by technologically sound topics (deep tech) from the life sciences, digital and high-tech sectors with the potential to decisively improve people's lives.
OCCIDENT Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cédric Barra
Senior Investment Manager (Life Sciences)
|
|||
Mirco Müller
Junior Investment Manager (Life Sciences)
|
|||
|
Paul Sunzenauer
Junior Investment Manager (Life Sciences)
|
|||
Simon Schild von Spannenberg
Investment Manager (Industrial Tech)
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Paul Sunzenauer invest in?
Paul Sunzenauer invests primarily in Life Science and Biotechnology startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Paul Sunzenauer last invest?
The most recent investment recorded for Paul Sunzenauer closed in Jul 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
